有恶性肿瘤病史的肺癌筛查患者中胸部及胸外恶性肿瘤的发生率
本研究纳入单中心5835例肺癌筛查CT,比较有或无恶性肿瘤病史患者的后续肺癌及胸外恶性肿瘤诊断率。有病史组肺癌1.4%、非肺癌2%,无病史组分别为1.9%和1.5%。多因素回归显示年龄预测后续恶性肿瘤(OR 1.6/十年,P<.0001),而恶性肿瘤病史无预测价值(P=.50)。
要点
- 有恶性肿瘤病史者肺癌及胸外恶性肿瘤风险与无病史者相似。
- 转诊医生判断低转移风险的有病史患者不应被排除在肺癌筛查之外。
诊断标准与关键数值
- 无恶性肿瘤病史组(4592次扫描):后续1年内肺癌诊断率1.9%(87例),非肺癌恶性肿瘤诊断率1.5%(68例)。
- 有恶性肿瘤病史组(1243次扫描,占21%):后续肺癌诊断率1.4%(17例),非肺癌恶性肿瘤诊断率2%(25例)。
- 多因素logistic回归:年龄预测后续恶性肿瘤(含肺癌),OR=1.6/十年(P<.0001);恶性肿瘤病史无预测价值(P=.50)。
局限性
- 单中心回顾性研究。
- 恶性肿瘤病史来源于账单记录,可能存在遗漏或错误分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The objective of this study was to assess whether a history of malignancy affects the incidence of extrathoracic malignancies and lung cancer in patients undergoing CT lung cancer screening (LCS).
METHODS: All patients who underwent a LCS CT between June 2014 and August 2018 in a single health care system were included. History of prior nonskin malignancy was extracted from billing records. Subsequent diagnoses of malignancy were extracted from clinical pathology reports. Risk for subsequent malignancy was compared between patients with and those without prior malignancy and evaluated using multivariate logistic regression including age and history of malignancy.
RESULTS: A total of 5,835 LCS CT studies were included, and 1,243 (21%) were performed on patients with diagnoses of malignancy before CT. For the 4,592 scans performed on patients without histories of malignancy, 87 patients (1.9%) were diagnosed with lung cancer and 68 (1.5%) were diagnosed with nonlung malignancies in the following year. Among patients with histories of malignancy, 17 (1.4%) were diagnosed with lung cancer, and 25 (2%) were diagnosed with nonlung malignancies. Logistic regression for subsequent diagnosis of malignancy (including lung cancer) demonstrated age to be predictive, with an odds ratio of 1.6 per decade (P < .0001); history of malignancy was not predictive of subsequent malignancy (P = .50).
CONCLUSIONS: Patients with histories of malignancy referred for LCS have a similar risk for developing lung cancers and extrathoracic malignancies as patients without histories of malignancy. Patients with histories of malignancy who are believed by their referring providers to be at low risk for metastasis should not be excluded from LCS.
引用
- Byrne SC, Hammer MM. Thoracic and Extrathoracic Malignancies in Lung Cancer Screening Patients With Histories of Malignancy. J Am Coll Radiol. 2021. PMID: 33891858. doi:10.1016/j.jacr.2021.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。